This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palucha, A.
Right arrow Articles by Gniadkowski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palucha, A.
Right arrow Articles by Gniadkowski, M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 1999, p. 393-396, Vol. 43, No. 2
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Diversification of Escherichia coli Expressing an SHV-Type Extended-Spectrum beta -Lactamase (ESBL) during a Hospital Outbreak: Emergence of an ESBL-Hyperproducing Strain Resistant to Expanded-Spectrum Cephalosporins

Andrzej Palucha,1 Barbara Mikiewicz,2 and Marek Gniadkowski1,*

Sera and Vaccines Central Research Laboratory, 00-725 Warsaw,1 and Health Care Center Praga-Pólnoc, 03-719 Warsaw,2 Poland

Received 18 May 1998/Returned for modification 7 September 1998/Accepted 5 November 1998

Twelve SHV-type extended-spectrum beta -lactamase (ESBL)-producing Escherichia coli lac mutant isolates were recovered in October 1997 from 11 patients of the neonatal ward in a Warsaw hospital. The outbreak was clonal; however, some of the isolates expressed a much higher level of resistance to several beta -lactam antibiotics, including expanded-spectrum cephalosporins. This phenotype has been attributed to beta -lactamase hyperproduction correlating with the multiplication of ESBL gene copies, as was demonstrated for representative isolates.


* Corresponding author. Mailing address: Sera and Vaccines Central Research Laboratory, ul. Chelmska 30/34, 00-725 Warsaw, Poland. Phone: (48) 22-651 46 70. Fax: (48) 22-41 29 49. E-mail: marekg{at}ibbrain.ibb.waw.pl.


Antimicrobial Agents and Chemotherapy, February 1999, p. 393-396, Vol. 43, No. 2
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Zienkiewicz, M., Kern-Zdanowicz, I., Golebiewski, M., Zylinska, J., Mieczkowski, P., Gniadkowski, M., Bardowski, J., Ceglowski, P. (2007). Mosaic Structure of p1658/97, a 125-Kilobase Plasmid Harboring an Active Amplicon with the Extended-Spectrum {beta}-Lactamase Gene blaSHV-5. Antimicrob. Agents Chemother. 51: 1164-1171 [Abstract] [Full Text]  
  • Naumiuk, L., Baraniak, A., Gniadkowski, M., Krawczyk, B., Rybak, B., Sadowy, E., Samet, A., Kur, J. (2004). Molecular Epidemiology of Serratia marcescens in Two Hospitals in Danzig, Poland, over a 5-Year Period. J. Clin. Microbiol. 42: 3108-3116 [Abstract] [Full Text]  
  • Shannon, K. P., French, G. L. (2004). Increasing resistance to antimicrobial agents of Gram-negative organisms isolated at a London teaching hospital, 1995-2000. J Antimicrob Chemother 53: 818-825 [Abstract] [Full Text]  
  • Fiett, J., Stankiewicz, M., Przondo-Mordarska, H., Hryniewicz, W., Gniadkowski, M. (2000). A Novel Complex Mutant beta -Lactamase, TEM-68, Identified in a Klebsiella pneumoniae Isolate from an Outbreak of Extended-Spectrum beta -Lactamase-Producing Klebsiellae. Antimicrob. Agents Chemother. 44: 1499-1505 [Abstract] [Full Text]  
  • Palucha, A., Mikiewicz, B., Hryniewicz, W., Gniadkowski, M. (1999). Concurrent outbreaks of extended-spectrum {beta}-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital. J Antimicrob Chemother 44: 489-499 [Abstract] [Full Text]